2m 2m 2m 2m 2m 2m 2m
MAPLIGHT THERAPE (MPLT)
NASDAQ
$28.65+$0.005 (+0.02%)
Price as of Jun 23, 2026 4:37 PM EDT- $1.3BMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
MAPLIGHT THERAPE (MPLT)
$28.65+$0.005 (+0.02%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
NOVO HOLDINGS A/S | 467.05% | 3.7M | 0 (0.00%) | Mar 31, 2026 |
FCPM III SERVICES B.V. | 408.75% | 3.2M | 0 (0.00%) | Mar 31, 2026 |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 354.97% | 2.8M | +2,757 (+0.10%) | Mar 31, 2026 |
GOLDMAN SACHS GROUP INC | 252.73% | 2.0M | +57,705 (+2.89%) | Mar 31, 2026 |
BLACKROCK, INC. | 169.73% | 1.3M | +244,217 (+18.23%) | Mar 31, 2026 |
BLUE OWL CAPITAL HOLDINGS LP | 127.44% | 1.0M | +678,871 (+67.49%) | Mar 31, 2026 |
NAN FUNG GROUP HOLDINGS LTD | 123.05% | 971,253 | 0 (0.00%) | Mar 31, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 89.19% | 704,037 | +56,627 (+8.04%) | Mar 31, 2026 |
iSHARES TRUST | 86.88% | 685,769 | +98,878 (+14.42%) | Mar 31, 2026 |
T. Rowe Price Small-Cap Stock Fund, Inc. | 79.27% | 625,724 | +137,972 (+22.05%) | Mar 31, 2026 |
T. Rowe Price Small-Cap Value Fund, Inc. | 78.72% | 621,328 | -851 (-0.14%) | Mar 31, 2026 |
T. Rowe Price Equity Funds, Inc. | 43.37% | 342,343 | +80,614 (+23.55%) | Mar 31, 2026 |
FIDELITY CONCORD STREET TRUST | 20.90% | 164,964 | +164,964 (+100.00%) | Feb 28, 2026 |
VANGUARD SCOTTSDALE FUNDS | 12.51% | 98,748 | +80,772 (+81.80%) | Feb 28, 2026 |
Current Ownership Distribution
- Institutions47.7M (87.53%)
- Mutual Funds6.8M (12.47%)
- Insiders0 (0.00%)
- Other0 (0.00%)
Insider Transactions
- 0.00% (0)Current InsiderOwnership (%, shares)
- 4Number of InsiderBuying (last 12 months)
- $289.3MAmount of InsiderBuying (last 12 months)
- 1Number of InsiderSelling (last 12 months)
- $82.9MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Malenka Robert C. | Sell | Feb 24, 2026 | $13,358.40 | 736 | $18.15 | 325,059 |
Malenka Robert C. | Sell | Feb 23, 2026 | $198,391.32 | 10,788 | $18.39 | 326,271 |
Malenka Robert C. | Sell | Feb 23, 2026 | $9,072.56 | 476 | $19.06 | 325,795 |
Pavlov George | Buy | Feb 20, 2026 | $177,171.20 | 9,920 | $17.86 | 25,000 |
Malenka Robert C. | Sell | Feb 20, 2026 | $39,575.85 | 2,195 | $18.03 | 337,059 |
Pavlov George | Buy | Feb 19, 2026 | $77,694.54 | 4,422 | $17.57 | 15,080 |
Pavlov George | Buy | Feb 18, 2026 | $186,301.84 | 10,658 | $17.48 | 10,658 |
Malenka Robert C. | Sell | Feb 13, 2026 | $220,632.36 | 12,116 | $18.21 | 339,254 |
Malenka Robert C. | Sell | Feb 11, 2026 | $4,338.00 | 241 | $18.00 | 351,370 |
Garnett Timothy John | Buy | Feb 10, 2026 | $252,678.36 | 14,124 | $17.89 | 14,124 |
Malenka Robert C. | Sell | Feb 10, 2026 | $119,990.64 | 6,622 | $18.12 | 351,611 |
Lillie James Woodruff Chief Scientific Officer | Award | Feb 05, 2026 | $0.00 | 31,395 | $0.00 | 31,395 |
Setia Vishwas Chief Financial Officer | Award | Feb 05, 2026 | $0.00 | 31,395 | $0.00 | 31,395 |
Kreitzer Anatol Chief Discovery Officer | Award | Feb 05, 2026 | $0.00 | 24,455 | $0.00 | 24,455 |
GILLIS JONATHAN CAAO and PAO | Award | Feb 05, 2026 | $0.00 | 24,455 | $0.00 | 24,455 |
Lillie James Woodruff Chief Scientific Officer | Award | Feb 05, 2026 | $0.00 | 7,730 | $0.00 | 298,862 |
Setia Vishwas Chief Financial Officer | Award | Feb 05, 2026 | $0.00 | 7,730 | $0.00 | 395,549 |
Kreitzer Anatol Chief Discovery Officer | Award | Feb 05, 2026 | $0.00 | 6,020 | $0.00 | 259,928 |
GILLIS JONATHAN CAAO and PAO | Award | Feb 05, 2026 | $0.00 | 6,020 | $0.00 | 254,523 |
Malenka Robert C. | Sell | Feb 03, 2026 | $18.00 | 1 | $18.00 | 358,233 |
Malenka Robert C. | Sell | Feb 02, 2026 | $126,842.78 | 7,039 | $18.02 | 358,234 |
Malenka Robert C. | Sell | Jan 30, 2026 | $119,743.32 | 6,612 | $18.11 | 365,273 |
Malenka Robert C. | Sell | Jan 29, 2026 | $394,410.10 | 21,262 | $18.55 | 371,885 |
Malenka Robert C. | Sell | Jan 28, 2026 | $109,054.60 | 5,860 | $18.61 | 393,811 |
Malenka Robert C. | Sell | Jan 28, 2026 | $12,649.20 | 664 | $19.05 | 393,147 |
Kroeger Christopher A. Chief Executive Officer | In Kind | Jan 27, 2026 | $3.7M | 204,146 | $17.98 | 1.6M |
GILLIS JONATHAN CAAO and PAO | In Kind | Jan 27, 2026 | $396,459.00 | 22,050 | $17.98 | 248,503 |
Foff Erin Pennock Chief Medical Officer | In Kind | Jan 27, 2026 | $802,195.68 | 44,616 | $17.98 | 390,475 |
Kreitzer Anatol Chief Discovery Officer | In Kind | Jan 27, 2026 | $756,940.02 | 42,099 | $17.98 | 253,908 |
Hanson Kristopher General Counsel | In Kind | Jan 27, 2026 | $467,605.86 | 26,007 | $17.98 | 183,852 |